Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats

International Dairy Journal

Volumn 20, Issue 4, 2010, Pages 231-235

  Di Marzo, Vincenzo ^a   Griinari, Mikko ^b   Carta, Gianfranca ^c   Murru, Elisabetta ^c   Ligresti, Alessia ^a   Cordeddu, Lina ^c   Giordano, Elena ^c   Bisogno, Tiziana ^a   Collu, Maria ^c   Batetta, Barbara ^c,d   Uda, Sabrina ^c   Berge, Kjetil ^e   Banni, Sebastiano ^c,d  

^a CNR   (Italy)

^b CLANET ltd ^*  (Finland)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d Nutrisearch srl   (Italy)

^e former employee of Aker BioMarine Antarctic AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ARACHIDONIC ACIDS; BENEFICIAL EFFECTS; BRAIN PHOSPHOLIPIDS; DOCOSAHEXAENOIC ACID; ENDOCANNABINOID; FATTY ACID PROFILES; HUMAN INTAKE; LINOLEIC; LINOLENIC ACIDS; LONG CHAIN POLYUNSATURATED FATTY ACID; LOW DOSE; MEMBRANE PHOSPHOLIPIDS; METABOLIC SYNDROMES; N-3 FATTY ACIDS; OBESE ZUCKER RAT; PERIPHERAL TISSUE;

ABERRATIONS; BIOCHEMISTRY; ENVIRONMENTAL PROTECTION AGENCY; FATTY ACIDS; METABOLISM; PHOSPHOLIPIDS; RATS;

ACIDS;

DECAPODA (CRUSTACEA); EUPHAUSIACEA; RATTUS; RODENTIA;

EID: 75549090956     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2009.11.015     Document Type: Article

References (26)

1. Artmann A., Petersen G., Hellgren L.I., Boberg J., Skonberg C., Nellemann C., et al. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochimica et Biophysica Acta 1781 (2008) 200-212
2. Banni S., Carta G., Contini M.S., Angioni E., Deiana M., Dessi M.A., et al. Characterization of conjugated diene fatty acids in milk, dairy products, and lamb tissues. Journal of Nutritional Biochemistry 7 (1996) 150-155
3. Banni, S. & Di Marzo, V. Effect of the diet on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. Molecular Nutrition and Food Research, accepted for publication.
4. Batetta B., Griinari M., Carta G., Murru E., Ligresti A., Cordeddu L., et al. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. Journal of Nutrition 139 (2009) 1495-1501
5. Berger A., Crozier G., Bisogno T., Cavaliere P., Innis S., and Di Marzo V. Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proceedings of the National Academy of Sciences U.S.A. 98 (2001) 6402-6406
6. Calder P.C. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. American Journal of Clinical Nutrition 83 (2006) 1505S-1519S
7. Christensen R., Kristensen P.K., Bartels E.M., Bliddal H., and Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370 (2007) 1706-1713
8. DeMar J.C., DiMartino Jr. C., Baca A.W., Lefkowitz W., and Salem Jr. N. Effect of dietary docosahexaenoic acid on biosynthesis of docosahexaenoic acid from alpha-linolenic acid in young rats. Journal of Lipid Research 49 (2008) 1963-1980
9. Di Marzo V. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia 51 (2008) 1356-1367
10. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410 (2001) 822-825
11. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry 226 (1957) 497-509
12. Gary-Bobo M., Elachouri G., Gallas J.F., Janiak P., Marini P., Ravinet-Trillou C., et al. Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology 46 (2007) 122-129
13. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proceedings of the National Academy of Sciences U.S.A. 102 (2005) 18620-18625
14. Ip C., Banni S., Angioni E., Carta G., McGinley J., Thompson H.J., et al. Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. Journal of Nutrition 129 (1999) 2135-2142
15. Kathuria S., Gaetani S., Fegley D., Valino F., Duranti A., Tontini A., et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nature Medicine 9 (2003) 76-81
16. Ligresti A., Petrosino S., and Di Marzo V. From endocannabinoid profiling to 'endocannabinoid therapeutics'. Current Opinion in Chemical Biology 13 (2009) 321-331
17. Lutz B. Endocannabinoid signals in the control of emotion. Current Opinion in Pharmacology 9 (2009) 46-52
18. Matias I., Carta G., Murru E., Petrosino S., Banni S., and Di Marzo V. Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. Biochimica et Biophysica Acta 1781 (2008) 52-60
19. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
20. Melis M.P., Angioni E., Carta G., Murru E., Scanu P., Spada S., et al. Characterization of conjugated linoleic acid and its metabolites by RP-HPLC with diode array detector. European Journal of Lipid Science and Technology 103 (2001) 617-621
21. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
22. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., and Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145 (2004) 5431-5438
23. Petrosino S., Ligresti A., and Di Marzo V. Endocannabinoid chemical biology: a tool for the development of novel therapies. Current Opinion in Chemical Biology 13 (2009) 309-320
24. Rapoport S.I., Rao J.S., and Igarashi M. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins, Leukotrienes, and Essential Fatty Acids 77 (2007) 251-261
25. Schmitz G., and Ecker J. The opposing effects of n-3 and n-6 fatty acids. Progress in Lipid Research 47 (2008) 147-155
26. Watanabe S., Doshi M., and Hamazaki T. n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins, Leukotrienes, and Essential Fatty Acids 69 (2003) 51-59